The Automatic Molecular Diagnostic System 1800/8800 is an automated in-house molecular diagnostic platform designed to perform nucleic acid extraction, amplification and detection with minimal manual intervention. It uses patented AIM cartridges, which contain all assay reagents in a ready-to-use format, enabling sample-to-result PCR testing in one streamlined workflow. The system integrates extraction, amplification, fluorescence detection, and reporting into a single instrument, making it suitable for clinics, veterinary hospitals, and small laboratory settings.
Integrates nucleic acid extraction, amplification, and detection in one system with minimal operator input.
Single-use cartridges containing all reagents reduce contamination risk and simplify testing.
AIMDX1800 for single sample testing and AIMDX8800 for multi-sample (up to 8) testing.
Rapid PCR results compared to conventional lab workflows.
Suitable for clinical, veterinary, and research diagnostics.
The Automatic Molecular Diagnostic System 1800/8800 enables rapid, high-accuracy molecular diagnostics directly at the point of care. Unlike traditional PCR workflows that require centralized labs and extensive manual steps, this system uses ready-to-use cartridges and automated cycling to provide timely results with less risk of contamination. Its dual configuration (single-sample and batch processing) makes it scalable for practices of any size, improving operational efficiency and patient care.
AIM-Bio is a biotechnology company dedicated to the research, development, and manufacturing of in-vitro diagnostic (IVD) products and solutions, including molecular diagnostic kits, automated PCR systems, immunoassays, and integrated diagnostic solutions for clinical and veterinary applications. Their mission is to make diagnostic testing faster, easier, and more accurate through automation and innovation.
